Skip to main content
Top

Molecular Diagnosis & Therapy

Issue 6/2008

Content (8 Articles)

Brain Injury

Biomarkers in the Clinical Diagnosis and Management of Traumatic Brain Injury

Georgene W. Hergenroeder, John B. Redell, Anthony N. Moore, Pramod K. Dash

Cancer

Diagnostic and Prognostic Sarcoma Signatures

Elai Davicioni, Daniel H. Wai, Michael J. Anderson

Cancer

Biomarkers for Malignant Pleural Mesothelioma

Laurent Greillier, Paul Baas, John J. Welch, Baktiar Hasan, Alexandre Passioukov

Short Communication

CXCL5 Gene Polymorphism Association with Diabetes Mellitus

Shirin Hasani Ranjbar, Parvin Amiri, Issam Zineh, Taimour Y. Langaee, Mahsa Namakchian, Ramin Heshmet, Mohammadali Sajadi, Mohammadreza Mirzaee, Ebrahim Rezazadeh, Parisa Balaei, Javad Tavakkoly Bazzaz, Miguel A. Gonzalez-Gay, Bagher Larijani, Mahsa M. Amoli

Original Research Article

ELISA Test to Detect CDKN2A (p16INK4a) Expression in Exfoliative Cells

Li Ding, Xian-jin Zou, Jin-e Ao, Ai-Xiang Yao, Lan Cai

Glossary

Glossary of Genetics/Genomics Terms

David Williamson, Anne Bardsley-Elliot

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine